Approach to the Patient With Thyrotoxicosis Using Telemedicine

Abstract Context The potential for endocrine care via telemedicine has been recognized since the early 2000s when clinical outcome data demonstrated improvements in glycemic control with telemedicine. The widespread use of telemedicine during the COVID-19 pandemic has pushed telemedicine beyond diab...

Full description

Saved in:
Bibliographic Details
Published in:The journal of clinical endocrinology and metabolism 2020-08, Vol.105 (8), p.2812-2818
Main Authors: Griffith, Michelle L, Bischoff, Lindsay A, Baum, Howard B A
Format: Article
Language:English
Subjects:
Adult
Approach to the Patient
Betacoronavirus
Care and treatment
Coronavirus Infections - prevention & control
COVID-19
Development and progression
Diabetes therapy
Endocrinology - methods
Epidemics
Female
Humans
Medical research
Medicine, Experimental
Pandemics - prevention & control
Pneumonia, Viral - prevention & control
SARS-CoV-2
Symptom Assessment - methods
Telemedicine
Telemedicine - methods
Thyroid diseases
Thyrotoxicosis - diagnosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Context The potential for endocrine care via telemedicine has been recognized since the early 2000s when clinical outcome data demonstrated improvements in glycemic control with telemedicine. The widespread use of telemedicine during the COVID-19 pandemic has pushed telemedicine beyond diabetes care and into clinical areas with a paucity of published data. The evaluation and treatment of thyrotoxicosis heavily relies on laboratory assessment and imaging with physical exam playing a role to help differentiate the etiology and assess the severity of thyrotoxicosis. Case Description We describe a patient presenting for evaluation of new thyrotoxicosis via telemedicine, and describe modifications to consider for thorough, safe evaluation via telemedicine. Conclusion Telemedicine may be an ideal way to assess and treat patients with thyrotoxicosis who are not able to physically attend a visit with an endocrinologist but still have access to a laboratory for blood draws. Potential challenges include access to imaging and high-volume surgeons if needed. Clinical and economic outcomes of telemedicine care of thyrotoxicosis should be studied so that standards of care for endocrine telemedicine can be established.
ISSN:0021-972X
1945-7197
DOI:10.1210/clinem/dgaa373